Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: A multistate analysis with follow-up beyond hospital discharge

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 2, 2011, Pages 381-386

  Wolkewitz, Martin ^a   Frank, Uwe ^a   Philips, Gabby ^b   Schumacher, Martin ^a   Davey, Peter ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Antibiotic resistance; Event history analysis; Hospital epidemiology; S. aureus; Statistical modelling

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; RISK ASSESSMENT; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PATIENT DISCHARGE; REGRESSION ANALYSIS; SCOTLAND; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 78651464260     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq424     Document Type: Article

References (25)

1. WHO. World Health Organization Report on Infectious Diseases 2000: Overcoming Antimicrobial Resistance. http://www.who.int/infectiousdisease-report/2000/.
2. Lawton RM, Fridkin SK, Gaynes RP et al. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/Infectious Diseases Society of America. Infect Control Hosp Epidemiol 2000; 21: 256-9.
3. Maragakis LL, Perencevich EN, Cosgrove SE. Clinical and economic burden of antimicrobial resistance. Expert Rev Anti Infect Ther 2008; 6: 751-63.
4. Cooper B, Medley G, Stone S et al. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci USA 2004; 101: 10223-8.
5. Rosdahl VT, Pedersen KB. The Copenhagen Recommendations. Report from the Invitational EU Conference on The Microbial Threat. Copenhagen, Denmark, 1998.
6. Beyersmann J, Gastmeier P, Wolkewitz M et al. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol 2008; 61: 1216-21.
7. Barnett AG, Batra R, Graves N et al. Using a longitudinal model to estimate the effect of methicillin-resistant Staphylococcus aureus infection on length of stay in an intensive care unit. Am J Epidemiol 2009; 170: 1186-94.
8. Wolkewitz M, Vonberg R, Grundmann H et al. Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models. Crit Care 2008; 12: R44.
9. Wolkewitz M, Beyersmann J, Gastmeier P et al. Modeling the effect of time-dependent exposure on intensive care unit mortality. Intensive Care Med 2009; 35: 826-32.
10. Cosgrove S, Sakoulas G, Perencevich E et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53-9.
11. Whitby M, McLaws M, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 2001; 175: 264-7.
12. Blot SI, Vandewoude KH, Hoste EA et al. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002; 162: 2229-35.
13. Wyllie D, Crook D, Peto T. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006; 333: 281.
14. Kaier K, Wilson C, Chalkley M et al. Health and economic impacts of antibiotic resistance in European hospitals - outlook on the BURDEN project. Infection 2008; 36: 492-4.
15. Sullivan FM, Pell JP, Sweetland M et al. How could primary care meet the informatics needs of UK Biobank? A Scottish proposal. Inform Prim Care 2003; 11: 129-35.
16. Anon. Scottish Surveillance of Healthcare Associated Infection Programme. Quarterly Report on Meticillin Resistant Staphylococcus aureus Bacteraemias in Scotland. January 2003 - March 2007. Glasgow: Health Protection Scotland, 2007.
17. Putter H, Fiocco M, Geskus R. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007; 26: 2389-430.
18. Allignol A, Beyersmann J, Schumacher M. mvna: an R package for the Nelson-Aalen estimator in multistate models. R News 2008; 8: 48-50.
19. R Development Core Team. R: A Language and Environment For Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2005. ISBN 3-900051-07-0. http://www.R-project.org.
20. Cerceo E, Lautenbach E, Linkin DR et al. Role of matching in case-control studies of antimicrobial resistance. Infect Control Hosp Epidemiol 2009; 30: 479-83.
21. Engemann J, Friedman J, Reed S et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 2005; 26: 534-9.
22. Reed S, Friedman J, Engemann J et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005; 26: 175-83.
23. Beyersmann J, Schumacher M. Time-dependent covariates in the proportional subdistribution hazards model for competing risks. Biostatistics 2008; 9: 765-76.
24. Hurley J. Comparison of mortality associated with methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia: an ecological analysis. Clin Infect Dis 2003; 37: 866-8.
25. Hurley J. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 2002; 176: 188; author reply 189.